MeSH D013272 - stomach diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005767:Gastrointestinal diseases
D013272:
Stomach diseases
D000126:Achlorhydria
0 Companies
0 Drugs
Success rate
D004383:Duodenogastric reflux
0 Companies
0 Drugs
Success rate
D005756:Gastritis
D010437:Peptic ulcer
D011178:Postgastrectomy syndromes
0 Companies
0 Drugs
Success rate
D013271:Gastric dilatation
0 Companies
0 Drugs
Success rate
D013274:Stomach neoplasms
D013275:Stomach rupture
0 Companies
0 Drugs
Success rate
D013277:Stomach volvulus
0 Companies
0 Drugs
Success rate
D015043:Zollinger-ellison syndrome
D017219:Gastric outlet obstruction
0 Companies
0 Drugs
Success rate
D018589:Gastroparesis
D020252:Gastric antral vascular ectasia
0 Companies
0 Drugs
Success rate
D045724:Stomach diverticulosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Casper Pharma | Metronidazole, Bismuth subsalicylate, Tetracycline | Helidac | 1996-08-15 | |||
| Nostrum Laboratories | Metronidazole, Bismuth subsalicylate, Tetracycline | Bismuth Subsalicylate, Metronidazole Tetracycline | 2018-11-30 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
63%5/8
Phase 3
13%1/8
Approved: 1Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use